Neuropeptides
Country
United Kingdom
Western Europe
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Medicine (miscellaneous)
Q2
└
Neurology
Q2
└
Cellular and Molecular Neuroscience
Q3
Publisher
SJR 2025
0.786
Q2
SJR Score
H-Index
83
Citations / Doc (2yr)
3.20
Total Docs. (latest)
47
Total Citations (3yr)
454
Publication type
Journals
ISSN
15322785, 01434179
Coverage
1980-2026
Journal Rank
#7,093
Subject Categories
Medicine (miscellaneous)
Q2
Neurology
Q2
Cellular and Molecular Neuroscience
Q3
Endocrine and Autonomic Systems
Q3
Endocrinology
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 47 |
| Total Docs. (3 years) | 151 |
| Total Refs. | 3,793 |
| Total Citations (3 years) | 454 |
| Citable Docs. (3 years) | 150 |
| Citations / Doc. (2 years) | 3.20 |
| Ref. / Doc. | 80.70 |
| % Female | 48.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Neuropeptides?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Neuropeptides has an SJR of 0.786 and is ranked Q2.
What is the SJR and quartile of Neuropeptides?
Neuropeptides has an SJR (SCImago Journal Rank) of 0.786 and its best quartile is Q2.
What is the H-index of Neuropeptides?
The H-index of Neuropeptides is 83, meaning 83 of its articles have each been cited at least 83 times.
Is Neuropeptides indexed in Scopus?
Yes. Neuropeptides is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.